A. Granzyme C (GzmC) expression in liver (Liv) and salivary gland (SG) CD3−NK1.1+NKp46+ cells of wild-type (WT) and Il15−/− mice. B. Experimental design of GzmcStat5b-CA mice. C. Kaplan-Meier survival curves for GzmcStat5b-CA/+, GzmcStat5b-CA/+Rag1−/−, and littermate control mice. D. GzmC+NK1.1+NKp46+ cells per gram of Liv tissue from seven-day-old WT and GzmcStat5b-CA/+ mice. E. Representative images of hematoxylin and eosin staining (H&E, first row) and NKp46 (second row) and cleaved caspase 3 (CC3, third row) immunoreactivities (indicated by arrows) of Liv sections from 14-day-old WT, GzmcStat5b-CA/+, and GzmcStat5b-CA/+Prf1−/− mice. Images and inserts are 200X and 400X, respectively. NKp46 and CC3 immunoreactivity was also quantified on serial sections as percent of total tissue using digital pathology software (Halo). Scale bar indicates 100 μm. F. Kaplan-Meier survival curves for GzmcStat5b-CA/+ and GzmcStat5b-CA/+Prf1−/− littermate control mice (n = 15–18 per group). Each dot represents one mouse; A, D, E: n = 3–4 mice per group, C: n = 7–18 per group, F: n = 15–18 mice per group. All data are combined from three or more independent experiments and shown as mean +/− SEM (A, D, E: one-way ANOVA with Tukey’s multiple comparisons test, C, F: Log-rank [Mantel Cox] test; “ns” = not significant, * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001)